+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Scar Treatment Market By Scar Type, By Product, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 220 Pages
  • May 2022
  • Region: Global
  • Allied Market Research
  • ID: 5640415
Scar is a mark remaining on the skin after injured tissue has healed. Scars are known to produce deep structural changes inside the deep layers of skin. Scares are classified into atrophic scars, hypertrophic scars, contractures, stretch marks, and keloid scars. Scar treatment is carried out to improve or reduce appearance of scars. It also restores function and corrects skin changes (disfigurement) caused by an injury, wound, poor healing, or previous surgery. Scars can be treated with radiation, lasers treatment, polyurethane dressing, silicone gel, corticosteroid injections, cryosurgery, and bleomycin injections.

Rise in number of road accidents and burn incidences boosts growth of the market. Road accidents and burn cases are responsible for scar formation. For instance, according to the National Highway Traffic Safety Administration (NHTSA) of the U.S. Department of Transportation in 2020, 38,680 people died in motor vehicle traffic crashes. in addition, some accients requires surgical operation which further contributes in the growth of scar treatment market.

Furthermore, increase in demand for cosmetic surgeries to improve appearance and restore scar marks propel growth of the market. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS) survey, in 2020 around 10,129,528 cosmetic surgical procedures were carried worldwide.

Moreover, increase in R&D activities and novel product launches in the market by key players boost the market growth. For instance, in September, 2021, SkinCeuticals, a leading medical skincare brand, launched Advanced scar control gel, specifically formulated for different types of scars and ideal complement to post-procedure scar care for procedures such as Mohs surgery and scar revision surgery. Furthermore, rise in number of hospitals and improvements in healthcare infrastructure further contributes toward the market growth. However, high cost of scar treatment limits growth of the market.

The scar treatment market is segmented on the basis of scar type, product, end user, and region. By scar type, the market is divided into atrophic scars, hypertrophic & keloid scars, contractures, and stretch marks. By product, it is divided into topical, laser-based treatment, and others. By end user, it is divided into hospitals, clinics, and home care. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the scar treatment market analysis from 2021 to 2031 to identify the prevailing scar treatment market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the scar treatment market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global scar treatment market size.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global scar treatment market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments


By Scar Type

  • Atrophic Scar
  • Hypertrophic and Keloid Scar
  • Contractures
  • Stretch Marks

By Product

  • Topical
  • Laser based treatment
  • Others

By End User

  • Hospitals
  • Clinics
  • Home Care

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Avita Medical Limited
  • Bausch Health Companies Inc.
  • Cynosure, Inc.
  • hra pharma
  • Mölnlycke Health Care AB
  • Polytech Health & Aesthetics GmbH
  • Sientra, Inc.
  • sisram inc
  • Smith and Nephew plc.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: SCAR TREATMENT MARKET, BY SCAR TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Atrophic Scar
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Hypertrophic and Keloid Scar
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Contractures
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Stretch Marks
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
CHAPTER 5: SCAR TREATMENT MARKET, BY PRODUCT
5.1 Overview
5.1.1 Market size and forecast
5.2 Topical
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Laser based treatment
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: SCAR TREATMENT MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Clinics
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Home Care
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: SCAR TREATMENT MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Scar Type
7.2.3 North America Market size and forecast, by Product
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Scar Type
7.2.5.1.2 Market size and forecast, by Product
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Scar Type
7.2.5.2.2 Market size and forecast, by Product
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Scar Type
7.2.5.3.2 Market size and forecast, by Product
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Scar Type
7.3.3 Europe Market size and forecast, by Product
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Scar Type
7.3.5.1.2 Market size and forecast, by Product
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Scar Type
7.3.5.2.2 Market size and forecast, by Product
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 U.K.
7.3.5.3.1 Market size and forecast, by Scar Type
7.3.5.3.2 Market size and forecast, by Product
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Scar Type
7.3.5.4.2 Market size and forecast, by Product
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Scar Type
7.3.5.5.2 Market size and forecast, by Product
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Scar Type
7.3.5.6.2 Market size and forecast, by Product
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Scar Type
7.4.3 Asia-Pacific Market size and forecast, by Product
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Scar Type
7.4.5.1.2 Market size and forecast, by Product
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Scar Type
7.4.5.2.2 Market size and forecast, by Product
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Scar Type
7.4.5.3.2 Market size and forecast, by Product
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Scar Type
7.4.5.4.2 Market size and forecast, by Product
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Scar Type
7.4.5.5.2 Market size and forecast, by Product
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Scar Type
7.4.5.6.2 Market size and forecast, by Product
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Scar Type
7.5.3 LAMEA Market size and forecast, by Product
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Scar Type
7.5.5.1.2 Market size and forecast, by Product
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Scar Type
7.5.5.2.2 Market size and forecast, by Product
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Scar Type
7.5.5.3.2 Market size and forecast, by Product
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Scar Type
7.5.5.4.2 Market size and forecast, by Product
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Avita Medical Limited
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Bausch Health Companies Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Cynosure, Inc.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 hra pharma
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Mölnlycke Health Care AB
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Polytech Health & Aesthetics GmbH
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Sientra, Inc.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 sisram inc
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Smith and Nephew plc.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
LIST OF TABLES
Table 1. Global Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 2. Scar Treatment Market Revenue, for Atrophic Scar, by Region, 2021-2031, ($Million)
Table 3. Scar Treatment Market for Atrophic Scar by Country, 2021-2031, ($Million)
Table 4. Scar Treatment Market Revenue, for Hypertrophic and Keloid Scar, by Region, 2021-2031, ($Million)
Table 5. Scar Treatment Market for Hypertrophic and Keloid Scar by Country, 2021-2031, ($Million)
Table 6. Scar Treatment Market Revenue, for Contractures, by Region, 2021-2031, ($Million)
Table 7. Scar Treatment Market for Contractures by Country, 2021-2031, ($Million)
Table 8. Scar Treatment Market Revenue, for Stretch Marks, by Region, 2021-2031, ($Million)
Table 9. Scar Treatment Market for Stretch Marks by Country, 2021-2031, ($Million)
Table 10. Global Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 11. Scar Treatment Market Revenue, for Topical, by Region, 2021-2031, ($Million)
Table 12. Scar Treatment Market for Topical by Country, 2021-2031, ($Million)
Table 13. Scar Treatment Market Revenue, for Laser Based Treatment, by Region, 2021-2031, ($Million)
Table 14. Scar Treatment Market for Laser Based Treatment by Country, 2021-2031, ($Million)
Table 15. Scar Treatment Market Revenue, for Others, by Region, 2021-2031, ($Million)
Table 16. Scar Treatment Market for Others by Country, 2021-2031, ($Million)
Table 17. Global Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 18. Scar Treatment Market Revenue, for Hospitals, by Region, 2021-2031, ($Million)
Table 19. Scar Treatment Market for Hospitals by Country, 2021-2031, ($Million)
Table 20. Scar Treatment Market Revenue, for Clinics, by Region, 2021-2031, ($Million)
Table 21. Scar Treatment Market for Clinics by Country, 2021-2031, ($Million)
Table 22. Scar Treatment Market Revenue, for Home Care, by Region, 2021-2031, ($Million)
Table 23. Scar Treatment Market for Home Care by Country, 2021-2031, ($Million)
Table 24. Scar Treatment Market, by Region, 2021-2031, ($Million)
Table 25. North America Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 26. North America Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 27. North America Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 28. North America Scar Treatment Market, by Country, 2021-2031, ($Million)
Table 29. U.S. Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 30. U.S. Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 31. U.S. Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 32. Canada Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 33. Canada Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 34. Canada Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 35. Mexico Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 36. Mexico Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 37. Mexico Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 38. Europe Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 39. Europe Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 40. Europe Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 41. Europe Scar Treatment Market, by Country, 2021-2031, ($Million)
Table 42. Germany Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 43. Germany Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 44. Germany Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 45. France Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 46. France Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 47. France Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 48. U.K. Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 49. U.K. Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 50. U.K. Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 51. Italy Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 52. Italy Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 53. Italy Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 54. Spain Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 55. Spain Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 56. Spain Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 57. Rest of Europe Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 58. Rest of Europe Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 59. Rest of Europe Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 60. Asia-Pacific Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 61. Asia-Pacific Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 62. Asia-Pacific Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 63. Asia-Pacific Scar Treatment Market, by Country, 2021-2031, ($Million)
Table 64. Japan Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 65. Japan Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 66. Japan Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 67. China Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 68. China Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 69. China Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 70. Australia Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 71. Australia Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 72. Australia Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 73. India Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 74. India Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 75. India Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 76. South Korea Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 77. South Korea Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 78. South Korea Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 79. Rest of Asia-Pacific Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 80. Rest of Asia-Pacific Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 81. Rest of Asia-Pacific Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 82. LAMEA Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 83. LAMEA Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 84. LAMEA Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 85. LAMEA Scar Treatment Market, by Country, 2021-2031, ($Million)
Table 86. Brazil Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 87. Brazil Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 88. Brazil Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 89. Saudi Arabia Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 90. Saudi Arabia Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 91. Saudi Arabia Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 92. South Africa Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 93. South Africa Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 94. South Africa Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 95. Rest of LAMEA Scar Treatment Market, by Scar Type, 2021-2031, ($Million)
Table 96. Rest of LAMEA Scar Treatment Market, by Product, 2021-2031, ($Million)
Table 97. Rest of LAMEA Scar Treatment Market, by End-user, 2021-2031, ($Million)
Table 98. Avita Medical Limited: Company Snapshot
Table 99. Avita Medical Limited: Operating Segments
Table 100. Avita Medical Limited: Product Portfolio
Table 101. Avita Medical Limited: Net Sales
Table 102. Avita Medical Limited: Key Stratergies
Table 103. Bausch Health Companies Inc.: Company Snapshot
Table 104. Bausch Health Companies Inc.: Operating Segments
Table 105. Bausch Health Companies Inc.: Product Portfolio
Table 106. Bausch Health Companies Inc.: Net Sales
Table 107. Bausch Health Companies Inc.: Key Stratergies
Table 108. Cynosure, Inc.: Company Snapshot
Table 109. Cynosure, Inc.: Operating Segments
Table 110. Cynosure, Inc.: Product Portfolio
Table 111. Cynosure, Inc.: Net Sales
Table 112. Cynosure, Inc.: Key Stratergies
Table 113. Hra Pharma: Company Snapshot
Table 114. Hra Pharma: Operating Segments
Table 115. Hra Pharma: Product Portfolio
Table 116. Hra Pharma: Net Sales
Table 117. Hra Pharma: Key Stratergies
Table 118. Mölnlycke Health Care Ab: Company Snapshot
Table 119. Mölnlycke Health Care Ab: Operating Segments
Table 120. Mölnlycke Health Care Ab: Product Portfolio
Table 121. Mölnlycke Health Care Ab: Net Sales
Table 122. Mölnlycke Health Care Ab: Key Stratergies
Table 123. Polytech Health & Aesthetics GmbH: Company Snapshot
Table 124. Polytech Health & Aesthetics GmbH: Operating Segments
Table 125. Polytech Health & Aesthetics GmbH: Product Portfolio
Table 126. Polytech Health & Aesthetics GmbH: Net Sales
Table 127. Polytech Health & Aesthetics GmbH: Key Stratergies
Table 128. Sientra, Inc.: Company Snapshot
Table 129. Sientra, Inc.: Operating Segments
Table 130. Sientra, Inc.: Product Portfolio
Table 131. Sientra, Inc.: Net Sales
Table 132. Sientra, Inc.: Key Stratergies
Table 133. Sisram Inc: Company Snapshot
Table 134. Sisram Inc: Operating Segments
Table 135. Sisram Inc: Product Portfolio
Table 136. Sisram Inc: Net Sales
Table 137. Sisram Inc: Key Stratergies
Table 138. Smith and Nephew plc.: Company Snapshot
Table 139. Smith and Nephew plc.: Operating Segments
Table 140. Smith and Nephew plc.: Product Portfolio
Table 141. Smith and Nephew plc.: Net Sales
Table 142. Smith and Nephew plc.: Key Stratergies
LIST OF FIGURES
Figure 1. Scar Treatment Market Segmentation
Figure 2. Scar Treatment Market, 2021-2031
Figure 3. Scar Treatment Market, 2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Scar Treatment Market:Drivers, Restraints and Opportunities
Figure 12. Scar Treatment Market, by Scar Type, 2021 (%)
Figure 13. Comparative Share Analysis of Atrophic Scar Scar Treatment Market, 2021-2031 (%)
Figure 14. Comparative Share Analysis of Hypertrophic and Keloid Scar Scar Treatment Market, 2021-2031 (%)
Figure 15. Comparative Share Analysis of Contractures Scar Treatment Market, 2021-2031 (%)
Figure 16. Comparative Share Analysis of Stretch Marks Scar Treatment Market, 2021-2031 (%)
Figure 17. Scar Treatment Market, by Product, 2021 (%)
Figure 18. Comparative Share Analysis of Topical Scar Treatment Market, 2021-2031 (%)
Figure 19. Comparative Share Analysis of Laser Based Treatment Scar Treatment Market, 2021-2031 (%)
Figure 20. Comparative Share Analysis of Others Scar Treatment Market, 2021-2031 (%)
Figure 21. Scar Treatment Market, by End-user, 2021 (%)
Figure 22. Comparative Share Analysis of Hospitals Scar Treatment Market, 2021-2031 (%)
Figure 23. Comparative Share Analysis of Clinics Scar Treatment Market, 2021-2031 (%)
Figure 24. Comparative Share Analysis of Home Care Scar Treatment Market, 2021-2031 (%)
Figure 25. Scar Treatment Market by Region, 2021
Figure 26. U.S. Scar Treatment Market, 2021-2031 ($Million)
Figure 27. Canada Scar Treatment Market, 2021-2031 ($Million)
Figure 28. Mexico Scar Treatment Market, 2021-2031 ($Million)
Figure 29. Germany Scar Treatment Market, 2021-2031 ($Million)
Figure 30. France Scar Treatment Market, 2021-2031 ($Million)
Figure 31. U.K. Scar Treatment Market, 2021-2031 ($Million)
Figure 32. Italy Scar Treatment Market, 2021-2031 ($Million)
Figure 33. Spain Scar Treatment Market, 2021-2031 ($Million)
Figure 34. Rest of Europe Scar Treatment Market, 2021-2031 ($Million)
Figure 35. Japan Scar Treatment Market, 2021-2031 ($Million)
Figure 36. China Scar Treatment Market, 2021-2031 ($Million)
Figure 37. Australia Scar Treatment Market, 2021-2031 ($Million)
Figure 38. India Scar Treatment Market, 2021-2031 ($Million)
Figure 39. South Korea Scar Treatment Market, 2021-2031 ($Million)
Figure 40. Rest of Asia-Pacific Scar Treatment Market, 2021-2031 ($Million)
Figure 41. Brazil Scar Treatment Market, 2021-2031 ($Million)
Figure 42. Saudi Arabia Scar Treatment Market, 2021-2031 ($Million)
Figure 43. South Africa Scar Treatment Market, 2021-2031 ($Million)
Figure 44. Rest of LAMEA Scar Treatment Market, 2021-2031 ($Million)
Figure 45. Top Winning Strategies, by Year
Figure 46. Top Winning Strategies, by Development
Figure 47. Top Winning Strategies, by Company
Figure 48. Product Mapping of Top 10 Players
Figure 49. Competitive Dashboard
Figure 50. Competitive Heatmap of Top 10 Key Players
Figure 51. Avita Medical Limited.: Net Sales, ($Million)
Figure 52. Bausch Health Companies Inc. Net Sales, ($Million)
Figure 53. Cynosure, Inc. Net Sales, ($Million)
Figure 54. Hra Pharma.: Net Sales, ($Million)
Figure 55. Mölnlycke Health Care Ab.: Net Sales, ($Million)
Figure 56. Polytech Health & Aesthetics GmbH.: Net Sales, ($Million)
Figure 57. Sientra, Inc. Net Sales, ($Million)
Figure 58. Sisram Inc.: Net Sales, ($Million)
Figure 59. Smith and Nephew PLC. Net Sales, ($Million)

Executive Summary

According to this report titled, 'Scar Treatment Market,' the scar treatment market size was valued at $13.1 billion in 2021, and is estimated to reach $32.4 billion by 2031, growing at a CAGR of 9.4% from 2022 to 2031.

Scarring is the process of external epidermal layer repair. Thus, scars result naturally as part of normal healing process in human body. Scars occur exactly at the site of wounds and nearby areas resulting in dark red fibrous tissue, which gradually becomes lighter in color. Scar treatment such as anti-scar gels and laser treatment are used to remove scar marks to enhance appearance.

Rise in demand for cosmetic corrections and availabilities of different anti-scar treatments drive growth of the market. Furthermore, rise in incidences of stretch marks, owing to heavy weight training and obesity drives demand for scar treatment. In addition, women have stretch marks owing to cesarean child delivery, which further contributes toward growth of the Scar Treatment Industry. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2020, cesarean delivery rate increased to 31.8%.

Furthermore, factors such as advancements in Scar Treatment Industry, increase in R&D activities, rise in number of hospitals and cosmetic clinics deives the Scar Treatment Market Growth. For instance, in April 2021, Pharmaxis, Australian pharmaceutical research company, in collaboration with the University of Western Australia (UWA) to start a world-first clinical trial to investigate a cream to stop scar forming after trauma, particularly following burn injuries. Furthermore, rise in awareness regarding scar treatment contributes toward growth of the scar treatment market.

Increase in prevalence of injuries and burn cases drive growth of the market. Infectious wounds tend to take longer healing time, which results in hypertrophic scar formation. In addition, rise in clinical trials for development of novel scar treatment contributes in growth of the market. For instance, in December 2020, according to a report published by Springer Nature, a global scientific publisher, intralesional 1470 nm bare-fiber diode laser shows promising results for treatment of hypertrophic scars. Furthermore, rise in trend of skin piercing further drives growth of the market. Skin piercing leads to formation of keloids. Thus, prevalence of wound injuries and R&D for novel treatment of hypertrophic scars boost growth of the market
The scar treatment market is segmented into by scar type, product, end user, and region.

On the basis of scar type, the market is divided into atrophic scar, hypertrophic & keloid scar, contractures, and stretch marks. The atrophic scar segment dominated the market in 2021, and is expected to dominate during the forecast period, owing to increase in prevalence of acne and chicken pox.

Depending on product, the market is classified into topical, laser-based treatment, and others. The topical segment have the largest Scar Treatment Market Share in 2021, and is expected to dominate during the forecast period, owing to easy availability of topical products and rise in consciousness regarding aesthetic appearance.

By end user, it is divided into hospitals, clinics, and home care. The home care segment dominated the Scar Treatment Market Forecast in 2021, and is expected to continue the same during the forecast period, owing to rise in number of retail pharmacies and high incidences of facial scars.

North America accounted for a majority of the global scar treatment market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to presence of key players in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in demand for aesthetic looks.

KEY FINDINGS OF STUDY

  • On the basis of scar type, the atrophic scar segment was the highest contributor to the market in 2021.
  • Depending on product, the topical segment was the highest contributor to the market in 2021.
  • By end user, hospital segment dominates the market in 2021.
  • Region wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Companies Mentioned

  • Avita Medical Limited
  • Bausch Health Companies Inc.
  • Cynosure, Inc.
  • hra pharma
  • Mölnlycke Health Care AB
  • Polytech Health & Aesthetics GmbH
  • Sientra, Inc.
  • sisram inc
  • Smith and Nephew plc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...